发明名称 |
Antibodies to fragment F1+2 of prothrombin, their production and use |
摘要 |
<p>An isolated peptide consisting of 5-25 amino acids, which includes amino acids 11-15 of a sequence having 62 amino acids fully defined in the specification (SEQ ID NO: 2), is new. - Independent claims are also included for: - (1) a method of immunization; - (2) methods of purifying or isolating an antibody or a substance; - (3) methods for the quantitative or qualitative detection of an analyte or prothrombin fragments F1+2 and/or F2 in a sample; - (4) an isolated antibody which binds specifically to the above peptide or to an epitope on the N-terminal half of the F2 fragment of prothrombin, or which is produced by the hybridoma cell line DSM ACC2607; - (5) a composition comprising the antibody and a pharmaceutical, sterile injection medium; - (6) a method of diagnosing a disease or disorder; - (7) a reagent comprising the above peptide or antibody; - (8) a test kit comprising the reagent; and - (9) an isolated cell or a hybridoma cell line that produces the above isolated antibody. - ACTIVITY - Anticoagulant; Thrombolytic. - No biological data given. - MECHANISM OF ACTION - Gene therapy; Vaccine.</p> |
申请公布号 |
EP1541676(B1) |
申请公布日期 |
2008.12.24 |
申请号 |
EP20040022637 |
申请日期 |
2004.09.23 |
申请人 |
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
发明人 |
TEIGELKAMP, STEFAN, DR.;BRAUN, KONRAD |
分类号 |
C12N9/74;G01N33/53;C07K7/06;C07K7/08;C07K14/47;C07K16/40;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N5/16;C12N5/20;G01N30/88;G01N33/68 |
主分类号 |
C12N9/74 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|